Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 1/20 | 0.63 |
| ▸ | NPBWR1 | P48145 | 6/20 | 0.56 |
| ▸ | IL23R | Q5VWK5 | 9/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.52 |
| ▸ | GHSR | Q92847 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29402493 | 0.98 | PRMT1 (0.61) | PRMT1NPBWR1IL23ROPRM1OPRD1 | |
| SCHEMBL29402413 | 0.92 | PRMT1 (0.67) | PRMT1NPBWR1IL23R | |
| SCHEMBL29754403 | 0.89 | GHSR (0.57) | PRMT1NPBWR1GHSR | |
| SCHEMBL31541502 | 0.88 | OPRM1 (0.55) | PRMT1OPRM1OPRD1GHSR | |
| SCHEMBL31433302 | 0.86 | PRMT1 (0.57) | PRMT1NPBWR1OPRM1OPRD1GHSR | |
| SCHEMBL29493326 | 0.86 | PRMT1 (0.63) | PRMT1NPBWR1IL23ROPRM1OPRD1 | |
| SCHEMBL29361028 | 0.84 | UTS2R (0.55) | PRMT1NPBWR1IL23RGHSR | |
| SCHEMBL29524863 | 0.84 | UTS2R (0.55) | PRMT1NPBWR1IL23RGHSR | |
| SCHEMBL31252910 | 0.84 | NPBWR1 (0.58) | PRMT1NPBWR1GHSR | |
| SCHEMBL29365946 | 0.83 | GHSR (0.64) | GHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368736-A1 | BISPECIFIC ANTIBODY | ONO PHARMACEUTICAL CO., LTD. (JP) | 2025-12-04 | — | — | US | disclosed |
| US-12325746-B2 | Bispecific antibody | ONO PHARMACEUTICAL CO., LTD. (JP) | 2025-06-10 | — | — | US | disclosed |
| US-12091461-B2 | Bispecific antibody | ONO PHARMACEUTICAL CO., LTD. (JP) | 2024-09-17 | — | — | US | disclosed |
| US-20240287187-A1 | BISPECIFIC ANTIBODY | ONO PHARMACEUTICAL CO., LTD. (JP) | 2024-08-29 | — | — | US | disclosed |
| US-20220372148-A1 | A PHARMACEUTICAL COMPOSITION FOR TREATING HEMATOLOGICAL CANCER | ONO PHARMACEUTICAL CO., LTD. (JP) | 2022-11-24 | — | — | US | disclosed |
| US-20220281977-A1 | BISPECIFIC ANTIBODY | ONO PHARMACEUTICAL CO., LTD. (JP) | 2022-09-08 | — | — | US | disclosed |
| US-20220185885-A1 | BISPECIFIC ANTIBODY | ONO PHARMACEUTICAL CO., LTD. (JP) | 2022-06-16 | — | — | US | disclosed |
| EP-4008348-A1 | BISPECIFIC ANTIBODY | ONO Pharmaceutical Co., Ltd. (JP) | 2022-06-08 | — | — | EP | disclosed |
| EP-3998081-A1 | TREATMENT OF HEMATOLOGIC CANCER WITH PD-1/CD3 DUAL SPECIFICITY PROTEIN | Ono Pharmaceutical Co., Ltd. (JP) | 2022-05-18 | — | — | EP | disclosed |
| EP-3978015-A1 | BISPECIFIC ANTIBODY | ONO Pharmaceutical Co., Ltd. (JP) | 2022-04-06 | — | — | EP | disclosed |